{
    "title": "A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design. (arXiv:2306.11768v1 [q-bio.QM])",
    "abstract": "Structure-based drug design (SBDD), which utilizes the three-dimensional geometry of proteins to identify potential drug candidates, is becoming increasingly vital in drug discovery. However, traditional methods based on physiochemical modeling and experts' domain knowledge are time-consuming and laborious. The recent advancements in geometric deep learning, which integrates and processes 3D geometric data, coupled with the availability of accurate protein 3D structure predictions from tools like AlphaFold, have significantly propelled progress in structure-based drug design. In this paper, we systematically review the recent progress of geometric deep learning for structure-based drug design. We start with a brief discussion of the mainstream tasks in structure-based drug design, commonly used 3D protein representations and representative predictive/generative models. Then we delve into detailed reviews for each task (binding site prediction, binding pose generation, \\emph{de novo} mo",
    "link": "http://arxiv.org/abs/2306.11768",
    "context": "Title: A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design. (arXiv:2306.11768v1 [q-bio.QM])\nAbstract: Structure-based drug design (SBDD), which utilizes the three-dimensional geometry of proteins to identify potential drug candidates, is becoming increasingly vital in drug discovery. However, traditional methods based on physiochemical modeling and experts' domain knowledge are time-consuming and laborious. The recent advancements in geometric deep learning, which integrates and processes 3D geometric data, coupled with the availability of accurate protein 3D structure predictions from tools like AlphaFold, have significantly propelled progress in structure-based drug design. In this paper, we systematically review the recent progress of geometric deep learning for structure-based drug design. We start with a brief discussion of the mainstream tasks in structure-based drug design, commonly used 3D protein representations and representative predictive/generative models. Then we delve into detailed reviews for each task (binding site prediction, binding pose generation, \\emph{de novo} mo",
    "path": "papers/23/06/2306.11768.json",
    "total_tokens": 947,
    "translated_title": "基于几何深度学习的结构药物设计系统综述",
    "translated_abstract": "结构药物设计利用蛋白质的三维几何结构来识别潜在的药物候选物，在药物发现中变得越来越重要。然而，基于物理化学建模和专家领域知识的传统方法费时费力。近年来，几何深度学习的发展，可以处理和整合三维几何数据，加上类似AlphaFold的工具提供准确的蛋白质三维结构预测，极大地推动了结构药物设计的进展。在本文中，我们系统地回顾了几何深度学习在结构药物设计中的最新进展。我们从结构药物设计中的主流任务、常用的3D蛋白质表示和预测/生成模型入手，然后详细介绍每个任务的回顾（例如结合位点预测、结合构象生成、\\emph{de novo} 分子设计等），并按不同的几何深度学习方法进行组织。最后，我们总结了该领域未来研究的挑战和前景。",
    "tldr": "本文在系统回顾几何深度学习在结构药物设计中的最新进展，分别讨论了不同任务并按不同的几何深度学习方法进行组织。该领域的前景看好，但仍存在挑战。",
    "en_tdlr": "This paper provides a systematic survey of recent advancements in geometric deep learning for structure-based drug design. It covers different tasks and methods and summarizes both the potential and challenges for future research in this field."
}